Dr. Viren Mehta has served as an independent non-executive director of YS Group since January 2021 and will continue to serve as independent director of YS Biopharma upon consummation of the Business Combination. Dr. Mehta has extensive experience in investment research and strategic advisory services, focusing on the pharmaceutical and biotechnology industry globally. He is the founder and managing member of Mehta Partners, LLC since February 1997. He has been a director of Onconova Therapeutics Inc., a company listed on Nasdaq (ONTX.US), since February 2004. From April 2013 to December 2017, Dr. Mehta served as the executive chair and co-founder of Gather Health Ltd, one of the early telehealth initiatives based in Hong Kong. Dr.Mehta served as a director of BlinkBio Inc. From September 2010 to December 2020.  From November 1999 to June 2010, Dr. Mehta served as a director of OSI Pharmaceuticals Inc., when Astellas of Japan acquired OSI for $4 billion. Dr. Mehta also actively works with not-for-profit-enterprises around the world focused on education, ecology, and healthcare.

Dr. Mehta received his Pharm.D. degree from the University of Southern California in August 1974 and his M.B.A. degree from the University of California, Los Angeles in December 1980.